Consort Nt (MLCNT) | Financial Analysis & Statements
Consort Nt. Mid-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2022Income Metrics
Revenue
378.9M
Gross Profit
134.1M
35.39%
Operating Income
118.6M
31.31%
Net Income
-24.3M
-6.42%
EPS (Diluted)
€-0.30
Balance Sheet Metrics
Total Assets
2.6B
Total Liabilities
704.5M
Shareholders Equity
1.3B
Debt to Equity
0.55
Cash Flow Metrics
Operating Cash Flow
140.9M
Free Cash Flow
45.0M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2022
Annual Income Flow
2024
Consort Nt Income Statement From 2022 to 2024
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 151.9M | 142.2M | 33.2M |
| Cost of Goods Sold | 93.7M | 87.8M | 29.6M |
| Gross Profit | 58.2M | 54.4M | 3.6M |
| Gross Margin % | 38.3% | 38.3% | 10.9% |
| Operating Expenses | |||
| Research & Development | - | - | - |
| Selling, General & Administrative | 1.2M | 946.0K | - |
| Other Operating Expenses | 20.2M | 16.8M | 62.6K |
| Total Operating Expenses | 21.4M | 17.7M | 62.6K |
| Operating Income | 5.9M | 9.2M | 3.5M |
| Operating Margin % | 3.9% | 6.5% | 10.4% |
| Non-Operating Items | |||
| Interest Income | 783.0K | 632.0K | 49.1K |
| Interest Expense | 265.0K | 218.0K | - |
| Other Non-Operating Income | - | - | - |
| Pre-tax Income | 4.9M | 9.2M | 6.4M |
| Income Tax | -876.0K | 1.8M | 1.0M |
| Effective Tax Rate % | -17.9% | 19.3% | 16.3% |
| Net Income | 5.8M | 7.4M | 6.2M |
| Net Margin % | 3.8% | 5.2% | 18.5% |
| Key Metrics | |||
| EBITDA | 7.0M | 10.2M | 3.5M |
| EPS (Basic) | - | €3.36 | - |
| EPS (Diluted) | - | €3.36 | - |
| Basic Shares Outstanding | - | 2197619 | - |
| Diluted Shares Outstanding | - | 2197619 | - |
Income Statement Trend
Consort Nt Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 17.3M | 17.4M | 5.0M | 257.5M | 232.3M |
| Short-term Investments | - | 2.0M | - | - | - |
| Accounts Receivable | 30.9M | 30.5M | 4.4M | 83.1M | 44.3M |
| Inventory | - | - | - | 50.1M | 56.8M |
| Other Current Assets | -1.0K | -345 | -10.6K | - | - |
| Total Current Assets | 83.6M | 81.6M | 25.1M | 517.2M | 620.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.4M | 2.2M | 0 | 242.5M | 261.8M |
| Goodwill | 4.5M | 4.5M | 13.9K | - | 0 |
| Intangible Assets | 44.0K | 45.0K | -140 | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | - | 24 | 283.9M | 303.0M |
| Total Non-Current Assets | 4.2M | 4.0M | 5.2M | 2.1B | 1.4B |
| Total Assets | 87.8M | 85.6M | 30.2M | 2.6B | 2.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 7.0M | 6.3M | 5.9M | 151.7M | 114.2M |
| Short-term Debt | 2.0M | 5.9M | 1.0M | 151.0M | 197.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 657.9K | 555.0K | 1.5M | 12.5M |
| Total Current Liabilities | 41.7M | 43.7M | 11.4M | 304.1M | 361.9M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.9M | 21.0K | 1.0M | 409.2M | 340.8M |
| Deferred Tax Liabilities | -15.0K | -16.0K | - | 4.3M | 3.2M |
| Other Non-Current Liabilities | 1.0K | 648.2K | 556.4K | - | - |
| Total Non-Current Liabilities | 4.1M | 1.9M | 1.4K | 411.8M | 344.1M |
| Total Liabilities | 45.8M | 45.6M | 11.4M | 716.0M | 706.0M |
| Equity | |||||
| Common Stock | 1.8M | 1.8M | 1.8M | 4.7B | 4.7B |
| Retained Earnings | - | 19.4M | 16.3M | -3.3B | -4.0B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 42.0M | 40.1M | 18.9M | 1.3B | 578.9M |
| Key Metrics | |||||
| Total Debt | 3.9M | 6.0M | 2.1M | 560.1M | 538.2M |
| Working Capital | 41.9M | 38.0M | 13.7M | 213.0M | 258.2M |
Balance Sheet Composition
Consort Nt Cash Flow Statement From 2019 to 2024
| Metric | 2024 | 2023 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 5.8M | 7.4M | 636.1M | -481.9M | 305.8M |
| Depreciation & Amortization | - | - | 126.7M | 258.9M | 376.0M |
| Stock-Based Compensation | - | - | 6.7M | 4.0M | 3.2M |
| Working Capital Changes | 0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | 5.8M | 7.4M | 766.9M | -142.6M | 543.4M |
| Investing Activities | |||||
| Capital Expenditures | -659.0K | -716.0K | -311.8M | -97.7M | -324.0M |
| Acquisitions | - | - | -6.4M | -2.8M | 4.3M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 7.0K | 9.0K | 4.0M | - | - |
| Investing Cash Flow | 1.3M | 294.0K | -183.0M | -178.5M | -367.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | -21.5M | -10.1M | -21.8M |
| Dividends Paid | -4.0M | -4.0M | 0 | -20.5M | -100.8M |
| Debt Issuance | - | 9.0K | 397.4M | - | 0 |
| Debt Repayment | -2.0M | -2.0M | -418.6M | -44.5M | -33.3M |
| Financing Cash Flow | -6.0M | -6.0M | -64.9M | -90.4M | -212.1M |
| Free Cash Flow | 3.9M | 1.2M | 15.6M | 129.0M | 174.4M |
| Net Change in Cash | 1.1M | 1.7M | 519.0M | -411.5M | -35.9M |
Cash Flow Trend
Consort Nt Key Financial Ratios
Valuation Ratios
Price to Book
3.37
Price to Sales
1.01
Profitability Ratios
Profit Margin
38.32%
Operating Margin
3.39%
Return on Equity
13.73%
Return on Assets
6.56%
Financial Health
Current Ratio
1.96
Debt to Equity
0.41
Per Share Data
Book Value per Share
€14.50
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| MLCNT | 154.1M | - | 3.37 | 13.73% | 38.32% | 0.41 |
| Capgemini SE | 16.6B | 10.85 | 1.44 | 13.70% | 7.13% | 81.03 |
| Sopra Steria | 2.3B | 7.97 | 1.12 | 14.72% | 5.26% | 55.22 |
| Neurones S.A | 891.4M | 17.76 | 2.49 | 12.05% | 6.08% | 0.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.